Evidence map›Paper›PMID 19897088›Full record

ArticleMethods in enzymology2009

Trait variability of cancer cells quantified by high-content automated microscopy of single cells.

Vito Quaranta, Darren R Tyson, Shawn P Garbett, Brandy Weidow, Mark P Harris, Walter Georgescu

Open access · greenAbstract read
In one paragraph

Article in Methods in enzymology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
7.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 24 citations in OpenAlex.

  1. A community-based approach to image analysis of cells, tissues and tumors.Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society · 2022
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Not all noise is waste.Nature methods · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Vito QuarantaDepartment of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Vanderbilt Integrative Cancer Biology Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Darren R TysonDepartment of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Vanderbilt Integrative Cancer Biology Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Shawn P GarbettVanderbilt Integrative Cancer Biology Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Brandy WeidowDepartment of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Vanderbilt Integrative Cancer Biology Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Mark P HarrisDepartment of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Walter GeorgescuVanderbilt Integrative Cancer Biology Center, Vanderbilt University Medical Center, Nashville, Tennessee, USA; Department of Biomedical Engineering, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Vanderbilt University Medical Center · US

Funding

TrainingU54CA113007 · NCI · VANDERBILT UNIVERSITY · PI ESTRADA-RODGERS, LOURDES · 2004 to 2014
$19.2M
MULTIDISCIPLINARY BASIC RESEARCH TRAINING IN CANCERT32CA009592 · NCI · VANDERBILT UNIVERSITY · PI Justin M Balko, Julie A Rhoades (Sterling) · 1987 to 2026
$10.4M
NEW CLASS OF TUMOR-ASSOCIATED ANTIGENSR01CA047858 · NCI · VANDERBILT UNIVERSITY · PI QUARANTA, VITO · 1988 to 2011
$3.7M
NCI NIH HHS R01 CA047858NCI NIH HHS T32 CA009592NCI NIH HHS U54 CA113007NCI NIH HHS U54CA113007
6 · The paper itself

Abstract

Mapping quantitative cell traits (QCT) to underlying molecular defects is a central challenge in cancer research because heterogeneity at all biological scales, from genes to cells to populations, is recognized as the main driver of cancer progression and treatment resistance. A major roadblock to a multiscale framework linking cell to signaling to genetic cancer heterogeneity is the dearth of large-scale, single-cell data on QCT-such as proliferation, death sensitivity, motility, metabolism, and other hallmarks of cancer. High-volume single-cell data can be used to represent cell-to-cell genetic and nongenetic QCT variability in cancer cell populations as averages, distributions, and statistical subpopulations. By matching the abundance of available data on cancer genetic and molecular variability, QCT data should enable quantitative mapping of phenotype to genotype in cancer. This challenge is being met by high-content automated microscopy (HCAM), based on the convergence of several technologies including computerized microscopy, image processing, computation, and heterogeneity science. In this chapter, we describe an HCAM workflow that can be set up in a medium size interdisciplinary laboratory, and its application to produce high-throughput QCT data for cancer cell motility and proliferation. This type of data is ideally suited to populate cell-scale computational and mathematical models of cancer progression for quantitatively and predictively evaluating cancer drug discovery and treatment.

Indexed as

NeoplasmsAlgorithmsBiomarkers, TumorCell LineCell ProliferationCellular StructuresComputational BiologyComputer SimulationHumansImage Processing, Computer-AssistedMicroscopy, FluorescencePhenotypeQuality ControlBiomarkers, Tumor

Identifiers

PMID19897088
PMCPMC2915824
OpenAlexW1512337159

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.